Profile
Full Name
Galera Therapeutics, Inc.Ticker Symbol
GRTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
November 7, 2019Indexes
Not includedWebsite
http://www.galeratx.comEmployees
3Key Details
Price
$0.02(-2.08%)
Market cap
$1.77M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.34(+74.44% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Galera Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 29, 23 Citigroup
NeutralAug 16, 23 HC Wainwright & Co.
NeutralAug 10, 23 Piper Sandler
NeutralJul 17, 23 HC Wainwright & Co.
BuyMar 22, 23 HC Wainwright & Co.
BuyFeb 21, 23 Piper Sandler
OverweightFeb 16, 23 HC Wainwright & Co.
BuyFeb 16, 23 B of A Securities
BuyMay 27, 22 B of A Securities
UnderperformDec 20, 21 Citigroup
BuyInstitutional Ownership
- What is the ticker symbol for Galera Therapeutics?
- Does Galera Therapeutics pay dividends?
- What sector is Galera Therapeutics in?
- What industry is Galera Therapeutics in?
- What country is Galera Therapeutics based in?
- When did Galera Therapeutics go public?
- Is Galera Therapeutics in the S&P 500?
- Is Galera Therapeutics in the NASDAQ 100?
- Is Galera Therapeutics in the Dow Jones?
- When was Galera Therapeutics's last earnings report?
- When does Galera Therapeutics report earnings?
- Should I buy Galera Therapeutics stock now?
What is the ticker symbol for Galera Therapeutics?
The ticker symbol for Galera Therapeutics is NASDAQ:GRTX
Does Galera Therapeutics pay dividends?
No, Galera Therapeutics does not pay dividends
What sector is Galera Therapeutics in?
Galera Therapeutics is in the Healthcare sector
What industry is Galera Therapeutics in?
Galera Therapeutics is in the Biotechnology industry
What country is Galera Therapeutics based in?
Galera Therapeutics is headquartered in United States
When did Galera Therapeutics go public?
Galera Therapeutics's initial public offering (IPO) was on November 7, 2019
Is Galera Therapeutics in the S&P 500?
No, Galera Therapeutics is not included in the S&P 500 index
Is Galera Therapeutics in the NASDAQ 100?
No, Galera Therapeutics is not included in the NASDAQ 100 index
Is Galera Therapeutics in the Dow Jones?
No, Galera Therapeutics is not included in the Dow Jones index
When was Galera Therapeutics's last earnings report?
Galera Therapeutics's most recent earnings report was on Dec 13, 2024
When does Galera Therapeutics report earnings?
The next expected earnings date for Galera Therapeutics is May 13, 2025
Should I buy Galera Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions